-
Jury awards former AstraZeneca sales manager $2.4M in whistleblower retaliation caseAstraZeneca and a former sales manager have each scored partial wins in the case of Suzanne Ivie, who alleged the company fired her after she raised concerns of off-label marketing. While a federal j2021/6/24
-
Horizon lays out $65M for in-house manufacturing plant as eye med Tepezza resets course to blockbusterlandAs Horizon Therapeutics' one-and-a-half-year-old thyroid eye disease med Tepezza starts to spread its wings, the drugmaker is standing up in-house manufacturing to help bluntany further supply disrup2021/6/24
-
With a Delaware site codenamed 'Project Dragonfly,' WuXi's STA plans to add 1,200 jobs in US expansion: reportsIt might sound like a codename in a spy movie spoof, but “Project Dragonfly” is in fact what STA Pharmaceutical has been calling its plan to build a massive manufacturing site in Delaware, according2021/6/23
-
Bristol Myers inks another Revlimid patent settlement—this time with Sun Pharma—as copycats nearAs Bristol Myers Squibb looks to guard Celgene’s top-selling cancer drug Revlimid from copycat competition, the company has inked a series of deals to welcome generic challengers in waves. India’s Su2021/6/23
-
Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, RegeneronAmgen’s high-profile PCSK9 patent fight with Sanofiand Regeneronhas attracted a who’s who of biopharma observers over the years,with many top companiesvoicingsupport foreach side. Now, Amgen has suff2021/6/21
-
Novavax's COVID-19 shot won't see much U.S. use, but a big global market awaits: analystIn rapidly developing a COVID-19 vaccine—and a highly effective one at that—Novavax got the hard part right. But the logistics of manufacturingthe vaccine has proven to be a more daunting task for th2021/6/21
-
GlaxoSmithKline gets no payday from high-profile trade-secrets theft caseAfter years of battling in courtand securing guilty pleas from two former GlaxoSmithKline researchers, federal prosecutors have come up short inconvincing the court to orderrestitution in a closely w2021/6/18
-
Building its world-leading flu vaccine capacity, Sanofi scores FDA nod for $425M plant in PAThree months after revealing a plan to build a €600 million flu vaccine plant in Toronto, Sanofi received good news about another flu shot factoryin North America. The FDA hasapprovedSanofi'snewly co2021/6/18
-
Danaher strikes $9.6B buyout for next-gen contract manufacturing player AldevronLooking to make a big splash in the next-gen pharma manufacturing market, Danaher haslaid out$9.6 billion to buy leading contract manufacturer Aldevron. Aldevron, founded in 1998, is a global player2021/6/16
-
BIO 2021: After COVID-19 showcased the power of science, J&J exec urges industry to start thinking 'cure' in cancerAmid COVID-19 lockdowns, routine cancer screenings were put on the back burner. While that may be a short-term harm from the pandemic, the crisis also showed the world that science can solve tough pr2021/6/16